NAKU
Dead / Abandoned — Abandoned — express abandonment (as of 26 Aug 2026)
What this means for you
This application is over — abandoned 26 Aug 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 99889749
- Mark type
- Word mark
- Filed
- 17 Jun 2026
- Abandoned
- 26 Aug 2026
- Attorney of record
- Joyce M. Ferraro
Goods and services
- Class 001 — Chemicals: Biological preparations for use in the pharmaceutical industry; biological preparations for scientific and research use; biological cell preparations for use in the pharmaceutical industry and for laboratory and scientific use; T-cells and gamma delta T-cells for use in the pharmaceutical industry and for laboratory and scientific use; cell cultures for use in the pharmaceutical industry and for laboratory and scientific use; biological materials for use in cellular engineering; biological materials for use in immunology research; cellular starting materials for use in the pharmaceutical industry and for laboratory and scientific use; biological preparations for use in the development of cellular therapies; biological materials for use in pharmaceutical and biomedical research
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for medical and therapeutic use; cellular preparations for medical and therapeutic use; T-cells and gamma delta T-cells for medical and therapeutic use; genetically engineered cellular preparations for medical and therapeutic use; engineered immune cell preparations for medical and therapeutic purposes; biological preparations for use in cellular therapy; cell-based therapeutic preparations; cellular therapeutic preparations for the treatment of cancer, infectious diseases and immune-related disorders
- Class 042 — Scientific and technological services: Pharmaceutical and biomedical research and development services; scientific research and development in the field of biotechnology, immunology, cell therapy, immunotherapy and regenerative medicine; scientific research relating to immune cells, T-cells, gamma delta T-cells, adoptive cell therapies and cancer therapies; laboratory research relating to cellular and genetic engineering; development of engineered immune cells and cellular therapeutic products for therapeutic applications; laboratory services relating to biotechnology and cellular manipulation; clinical research services; scientific consultancy relating to biotechnology, immunotherapy and pharmaceutical development; providing scientific information relating to cellular therapies and immunotherapeutics
Owner
- Ferring B.V., Hoofddorp, NL
Prosecution history
- 26 Aug 2026 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 26 Aug 2026 — ABANDONMENT - EXPRESS MAILED
- 26 Aug 2026 — ASSIGNED TO EXAMINER
- 19 Aug 2026 — TEAS EXPRESS ABANDONMENT RECEIVED
- 17 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Jun 2026 — NEW APPLICATION ENTERED